ANIP — ANI Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.92bn
- $2.21bn
- $883.37m
ANI Pharma rises on Q3 results beat, FY revenue forecast raise
ANI Pharmaceuticals beats Q3 revenue estimates on Cortrophin demand
Brief: ANI Pharmaceuticals Q3 Adjusted EPS USD 2.04 Vs. IBES Estimate USD 1.75
U.S. RESEARCH ROUNDUP- Autozone, Pfizer, Valley National Bancorp
Does a common heart attack pill help everyone? Studies disagree
U.S. RESEARCH ROUNDUP -ANI Pharmaceuticals, Berkshire Hathaway, Chevron
ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
ANI Pharmaceuticals beats Q2 revenue, EPS beats estimates and raises FY forecast
ANI Pharmaceuticals Inc expected to post earnings of $1.42 a share - Earnings Preview
Brief: Cg Oncology Inc Delaware Superior Court Jury Issues Unanimous Verdict That Co Owes No Future Royalties Or Other Payments To Ani Pharmaceuticals
Brief: Ani Pharmaceuticals Announces Results From New Day Clinical Trial Of Iluvien® For Use In Patients With Diabetic Macular Edema (Dme)
U.S. STOCKS ON THE MOVE-Compass, Rumble, Tesla
U.S. STOCKS ON THE MOVE-HCI Group, Tesla, Kingstone
ANI Pharma rises after lifting 2025 forecasts
ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: ANI Pharmaceuticals Announces The Launch Of Nitazoxanide Tablets
Brief: ANI Pharmaceuticals Announces Buyout Of Royalty Obligation For Iluvien And Yutiq
U.S. STOCKS ON THE MOVE-Washington Trust, Centessa Pharma, Kingstone
U.S. STOCKS ON THE MOVE-ANI Pharma, Ulta Beauty, KeyCorp